{"id":"W2925046483","doi":"10.1080/21645515.2019.1591139","title":"A product review of vedolizumab in inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Human Vaccines & Immunotherapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Addressin; Inflammatory bowel disease; Ulcerative colitis; Pharmacodynamics; Crohn's disease; Ustekinumab; Pharmacology; Immunology; Internal medicine; Tumor necrosis factor alpha; Infliximab; Disease; Pharmacokinetics; Integrin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004796885,0.0008057688,0.001498066,0.0002513465,0.00006129698,0.00003043069,0.0009573704,0.0003105996,0.0001515353],"category_scores_gemma":[0.00009810279,0.0007402909,0.0009409617,0.0001974892,0.00008300495,0.00001050852,0.0002798764,0.0003754088,0.0000912633],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009335013,"about_ca_system_score_gemma":0.001087165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003808693,"about_ca_topic_score_gemma":0.000009286952,"domain_scores_codex":[0.9963441,0.000435391,0.001604386,0.0008181306,0.0003040394,0.0004939279],"domain_scores_gemma":[0.9963546,0.00002381801,0.000959549,0.002324566,0.0002137579,0.0001237001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003159838,0.0004657332,0.001682935,0.7439715,0.0009529601,0.000143152,0.00004319757,0.000005992166,0.0002879761,0.000326099,0.002053842,0.2497506],"study_design_scores_gemma":[0.0007258461,0.00006068968,0.003260137,0.07127965,0.0009972614,0.0000129641,0.000002920261,0.000001048954,0.00001388367,0.00001817642,0.9228736,0.0007538156],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009707985,0.995834,0.000002024632,0.00001369005,0.0002882128,0.002516222,0.00009971645,0.00002599693,0.0002493614],"genre_scores_gemma":[0.0001681083,0.996769,0.00002217427,0.0003185577,0.000335509,0.0002763176,0.0008724315,0.00022136,0.001016573],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9208198,"threshold_uncertainty_score":0.9995048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03251273264421737,"score_gpt":0.3283188723708608,"score_spread":0.2958061397266434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}